These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9274650)

  • 41. Rituximab for the treatment of epidermolysis bullosa acquisita: A large case series of 15 patients.
    Dasdar S; Kianfar N; Tavakolpour S; Balighi K; Mahmoudi H; Daneshpazhooh M
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):779-784. PubMed ID: 37345887
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pharmaclinics--how I treat... Crohn disease].
    Belaiche J
    Rev Med Liege; 1995 Oct; 50(10):409-10. PubMed ID: 7491437
    [No Abstract]   [Full Text] [Related]  

  • 43. Clear-cell carcinoma of the lung in a patient treated with cyclosporine for epidermolysis bullosa acquisita.
    Klein JS; Goldin HM; Keegan C; Shiomoto G; Israel SR; Bronson DM
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):297. PubMed ID: 2007684
    [No Abstract]   [Full Text] [Related]  

  • 44. Epidermolysis bullosa acquisita associated with psoriasis.
    Kabashima R; Hino R; Bito T; Kabashima K; Nakamura M; Bungo O; Hashimoto T; Tokura Y
    Acta Derm Venereol; 2010 May; 90(3):314-6. PubMed ID: 20526561
    [No Abstract]   [Full Text] [Related]  

  • 45. [Acute pseudo-membranous laryngitis in epidermolysis bullosa acquisita].
    Lecomte H; Folia M; Muller G; Gilbert D; Tron F; Besancenot JF; Romanet P
    Rev Med Interne; 2010 May; 31(5):e7-10. PubMed ID: 20413194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidermolysis bullosa acquisita treated with rituximab.
    Mendes SR; Coutinho I; Cardoso JC
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34257124
    [No Abstract]   [Full Text] [Related]  

  • 47. Nitric oxide-releasing mesalamine: potential utility for treatment of inflammatory bowel disease.
    Wallace JL
    Dig Liver Dis; 2003 May; 35 Suppl 2():S35-40. PubMed ID: 12846442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidermolysis bullosa acquisita: correlation of IgE levels with disease activity under successful betamethasone/dapsone combination therapy.
    Miyake H; Morishima Y; Komai R; Hashimoto T; Kishimoto S
    Acta Derm Venereol; 2001; 81(6):429. PubMed ID: 11859948
    [No Abstract]   [Full Text] [Related]  

  • 49. Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid-sparing agent.
    Tran MM; Anhalt GJ; Barrett T; Cohen BA
    J Am Acad Dermatol; 2006 Apr; 54(4):734-6. PubMed ID: 16546607
    [No Abstract]   [Full Text] [Related]  

  • 50. Fatal Pseudomona pneumonia following rituximab therapy in a patient with epidermolysis bullosa acquisita.
    Mercader P; Rodenas JM; Peña A; Mascaro JM
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1141-2. PubMed ID: 17714160
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita.
    Marzano AV; Cozzani E; Biasin M; Russo I; Alaibac M
    Arch Dermatol Res; 2016 May; 308(4):273-6. PubMed ID: 26895535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidermolysis bullosa acquisita responsive to cyclosporin therapy.
    Khatri ML; Benghazeil M; Shafi M
    J Eur Acad Dermatol Venereol; 2001 Mar; 15(2):182-4. PubMed ID: 11495534
    [No Abstract]   [Full Text] [Related]  

  • 53. Epidermolysis bullosa acquisita.
    Van't Veen AJ; Heule F; Vuzevski VD; den Hengst CW
    Br J Dermatol; 1994 Nov; 131(5):724-5. PubMed ID: 7999613
    [No Abstract]   [Full Text] [Related]  

  • 54. Peristomal epidermolysis bullosa acquisita in a patient with Crohn's disease.
    Ormaechea-Pérez N; Tuneu-Valls A; Borja-Consigliere HA; Alcazar-Viladomiu ED; Jaka-Moreno A
    Acta Derm Venereol; 2014 Jul; 94(4):489-90. PubMed ID: 24322876
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of intravenous immunoglobulins for the treatment of mucous membrane pemphigoid-like epidermolysis bullosa acquisita.
    Komori T; Dainichi T; Kusuba N; Otsuka A; Hashimoto T; Kabashima K
    Eur J Dermatol; 2017 Oct; 27(5):563-564. PubMed ID: 29084648
    [No Abstract]   [Full Text] [Related]  

  • 56. Epidermolysis bullosa acquisita involving the vulva.
    Kassels A; Chuba N; Kraus CN
    Am J Obstet Gynecol; 2024 Jan; 230(1):99-100. PubMed ID: 37506750
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita.
    Letko E; Bhol K; Anzaar F; Perez VL; Ahmed AR; Foster CS
    Arch Ophthalmol; 2006 Nov; 124(11):1615-8. PubMed ID: 17102010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superpotent topical steroid therapy for epidermolysis bullosa acquisita.
    Abecassis S; Joly P; Genereau T; Courville P; André C; Moussalli J; Chosidow O
    Dermatology; 2004; 209(2):164-6. PubMed ID: 15316178
    [No Abstract]   [Full Text] [Related]  

  • 59. Epidermolysis bullosa acquisita and neuroendocrine pancreatic cancer - Coincidence or patho-genetic relationship?
    Busch JO; Sticherling M
    J Dtsch Dermatol Ges; 2007 Oct; 5(10):916-8. PubMed ID: 17910674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.